Mabtech — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Mabtech is a well-established, privately-held provider of specialized immunoassay kits, instruments, and reagents for the global life science research market. With a nearly 40-year history, the company has built a strong reputation for reliable products used in critical areas like immunotherapy development, vaccine research, and infectious disease studies. It operates on a product and service-based business model, generating revenue through direct sales and distributor networks, and supports its customers with extensive educational resources and custom development services. The company is strategically positioned in the growing cell and gene therapy analytical tools market.

Antibodies

Technology Platform

Developer and manufacturer of immunoassay kits, reagents, and instruments, with core expertise in ELISpot, FluoroSpot, and a flow-free multiplex platform (EYRAplex) for analyzing cytokine secretion and cellular immune responses.

Opportunities

Strong growth in cell and gene therapy (CGT) and immunotherapy markets drives demand for robust potency assays like ELISpot/FluoroSpot.

Expansion of its multiplex EYRAplex platform into new analyte menus and applications presents a significant product extension opportunity.

Increasing regulatory emphasis on cytokine release assays for therapy characterization creates a tailwind for adoption in clinical development.

Risk Factors

Competition from large, diversified life science tools companies and newer high-throughput single-cell analysis technologies.

Dependence on research funding cycles and pharmaceutical R&D budgets in its core immunology markets.

Risks associated with supply chain for biological reagents and potential intellectual property disputes in the antibody space.

Competitive Landscape

Mabtech competes in the niche but competitive field of cellular immunoassays. Key competitors include large players like Bio-Techne (through its ACD and R&D Systems divisions), Thermo Fisher Scientific, and BD Biosciences, which offer broad portfolios. It also faces competition from specialized ELISpot/FluoroSpot providers like Cellular Technology Limited (CTL) and newer entrants in multiplex protein detection. Mabtech differentiates through high-quality matched antibody pairs, integrated instrument systems, and a strong focus on user education and support.

More companies in Sweden →